Deep Tech Biotech: $75M Series C

The Challenge

A deep tech biotech company with promising R&D needed to transition to a commercial focus to attract growth capital. The transformation required both strategic repositioning and execution of a significant fundraising round.

Key challenges included:

• Transitioning from R&D to commercial focus
• Raising significant growth capital
• Building commercial capabilities from scratch
• Maintaining R&D excellence during transition

Our Approach

Our advisor led the strategic transformation and fundraising:

Strategic Repositioning

• Developed commercial-focused strategy
• Built go-to-market planning and capabilities
• Created compelling investor narrative

Fundraising Leadership

• Led Series C preparation and execution
• Built investor pipeline and relationships
• Negotiated terms and closed round

Additional Value Creation

• Secured non-dilutive funding sources
• Conducted M&A due diligence for strategic options
• Built commercial team and capabilities

Results

The transformation and fundraising delivered exceptional results:

• $75M Series C raised successfully
• £2M+ in non-dilutive funding secured
• $10B+ M&A due diligence conducted
• Strategic transformation to commercial focus

Key Takeaways

This engagement demonstrated that successful fundraising requires more than financial preparation—it requires strategic transformation. By combining growth strategy with financial leadership, the fundraising succeeded at scale.